MetLife Investment Management, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,328,654
-13.0%
63,7550.0%0.01%0.0%
Q2 2023$1,526,932
+27.3%
63,7550.0%0.01%
+22.2%
Q1 2023$1,199,869
+13.6%
63,755
-3.9%
0.01%
+12.5%
Q4 2022$1,056,308
-2.7%
66,3510.0%0.01%
-11.1%
Q3 2022$1,085,502
+16.1%
66,3510.0%0.01%
+12.5%
Q2 2022$934,886
-41.8%
66,3510.0%0.01%
-27.3%
Q1 2022$1,607,021
+59.8%
66,351
+54.0%
0.01%
+22.2%
Q4 2021$1,005,627
+40.5%
43,0860.0%0.01%
+28.6%
Q3 2021$715,658
-31.9%
43,0860.0%0.01%
-30.0%
Q2 2021$1,050,868
-48.4%
43,086
-10.6%
0.01%
-65.5%
Q1 2020$2,035,309
-1.2%
48,1730.0%0.03%
+38.1%
Q4 2019$2,060,841
+24.2%
48,173
+4.5%
0.02%
+10.5%
Q3 2019$1,659,427
+25.0%
46,108
-7.2%
0.02%
+26.7%
Q2 2019$1,327,706
-0.4%
49,6710.0%0.02%0.0%
Q1 2019$1,333,666
+80.0%
49,671
+8.4%
0.02%
+66.7%
Q4 2018$740,893
-22.1%
45,8190.0%0.01%
-10.0%
Q3 2018$951,202
+35.9%
45,8190.0%0.01%
+25.0%
Q2 2018$700,00045,8190.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders